If you're checking a Boswellia label for the AKBA percentage, here's why it matters. AKBA is the active boswellic acid in Boswellia serrata extract, and benefit in the research tracks AKBA content, not the extract's weight. A label that gives milligrams of extract without the AKBA percentage doesn't tell you how much of that compound you're getting.
What an AKBA percentage tells you
"Standardised to 30% AKBA" means 30% of the extract's weight is AKBA. So 100 mg of a 30% extract has 30 mg of AKBA, and the same arithmetic works on any label that prints both numbers. Without the percentage, you can't do the math.
The trial that tied a dose to an AKBA percentage
A dose-ranging randomized controlled trial in people with knee osteoarthritis found benefit at 100 mg and 250 mg a day of an extract standardised to 30% AKBA (Sengupta et al., Arthritis Res Ther, 2008, PMID 18667054). Another randomized controlled trial, using 100 mg a day of an extract called Aflapin, reported onset by day five (Vishal et al., Int J Med Sci, 2011, PMID 22022214). The full trial results are in Boswellia for osteoarthritis: what the research actually shows.
Why the extract mattered in the 2024 analysis
An earlier meta-analysis of 7 randomized controlled trials in people with diagnosed knee osteoarthritis found WOMAC pain scores 14.22 points lower (95% CI -22.34 to -6.09), with stiffness 10.04 and function 10.75 points lower (Yu et al., BMC Complement Med Ther, 2020, PMID 32680575). A 2024 systematic review and sub-group meta-analysis pooled 9 trials with 712 participants and found VAS pain scores 10.71 points lower overall (Dubey et al., Explore (NY), 2024, PMID 38365549).
The 2024 analysis then split the trials by extract. The standardized extract Aflapin showed a larger VAS reduction than the other Boswellia extracts, 16.09 points versus 4.68. The authors say that difference needs confirming in more comparative studies, and all three list affiliations with the company Sundyota Numandis Probioceuticals. Read it as a strong hint that the extract matters, not as settled.
What the Daily Detox® label says
Daily Detox® lists 400 mg of Boswellia serrata extract. It doesn't print an AKBA percentage. We don't have that number yet, and we won't guess at it.
That means you can't map our 400 mg onto the trials above. By raw weight it is above the 100 to 250 mg trial doses, but a 400 mg extract at a low AKBA percentage could deliver less active material than a standardised 100 mg dose. Until the percentage is on the label, our Boswellia is promising rather than settled. What we claim for it is narrow: Boswellia supports joint comfort and helps maintain a normal range of motion.
Frequently asked questions
What AKBA percentage did the dose-ranging trial use?
30% AKBA, with benefit at 100 mg and 250 mg a day in people with knee osteoarthritis (Sengupta et al., Arthritis Res Ther, 2008, PMID 18667054).
How do I work out the AKBA in a Boswellia extract?
Multiply the extract weight by the AKBA percentage. 100 mg at 30% is 30 mg of AKBA. If the label doesn't print the percentage, you can't work it out.
What AKBA percentage is in Daily Detox®?
The label states 400 mg of Boswellia serrata extract and no AKBA percentage. We don't have that number yet, so we don't state one.
Which Boswellia extract did best in the 2024 analysis?
Aflapin, a standardized extract, showed a VAS pain reduction of 16.09 points versus 4.68 for other Boswellia extracts. The authors say more comparative studies need to confirm it (Dubey et al., Explore (NY), 2024, PMID 38365549).
Does more milligrams of extract mean more AKBA?
Not necessarily. Benefit in the research tracks AKBA content, and a large extract at a low percentage can hold less AKBA than a small one at a high percentage.
See the full label
Daily Detox® prints every dose on the tin, eight actives and no proprietary blend, so you can check each one against the research above. Read the Daily Detox® label.
Before you start any supplement: talk to your doctor, especially if you take prescription medication, are pregnant or nursing, or live with a medical condition. If you take urate-lowering medication for gout, keep taking it.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.